Diligence memo · auto-generated · as of July 2, 2026
Affymax Inc
Affymax Inc has raised $42M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Affymax Inc operates in Biotechnology, based in PALO ALTO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Affymax Inc has raised $42M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $42M on 2009-03-02.
Most recent recorded round closed around 2009-03-02.
Valuation (modeled)modeled
Provath models Affymax Inc at approximately $1.7B (range $130M–$4.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 17.3 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 79% of Biotechnology peers (4293 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: Align Technology Inc, Helicon Therapeutics Inc.
Peoplefiled
13 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.